Regulations

(Sopone Nawoot/iStock via Getty Images Plus)

First FDA COVID-19 update of 2021

By Jenni Spinner

As healthcare providers and other high-priority patients begin receiving the vaccines, the agency continues to act to help the national pandemic response.

(Artisanova/iStock via Getty Images Plus)

Advarra acquires Longboat

By Jenni Spinner

The clinical site services provider continues its series of strategic company purchases by bringing the Irish trial technologies firm under its umbrella.

(Nitin Chavan/iStock via Getty Images Plus)

FDA grants EUA for combo COVID-19 treatment

By Jenni Spinner

The agency has given the go-ahead for use of baricitinib in conjunction with remdesivir for treating patients hospitalized with severe cases of the virus.

(12963734/iStock via Getty Images Plus)

FDA COVID-19 news roundup this week

By Jenni Spinner

The federal agency has offered updates, advice and action regarding the COVID-19 pandemic, helping life-sciences professionals stay on top of developments.

(DonkeyWorx/iStock via Getty Images Plus)

Latest FDA updates on COVID-19 battle

By Jenni Spinner

As the pandemic maintains a grip on the globe, the federal agency continues to offer advice and take action to guide life-sciences professionals.

(peterschreiber.media/iStock via Getty Images Plus)

FDA okays first COVID-19 treatment

By Jenni Spinner

The agency has approved the antiviral drug Veklury (remdesivir), produced by Gilead, for hospitalized patients 12 years and over diagnosed with the virus.

(olegback/iStock via Getty Images Plus)

CPhI Festival of Pharma

CPhI Pharma Awards recognize industry achievements

By Jenni Spinner

The 17th annual awards program, announced during the CPhI Festival of Pharma virtual event, hails professionals from various aspects of the industry.

Follow us

Product Innovations

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...